Science Explorer Back to mapMap
Researcher · UCB Pharma (Belgium) · Belgium

Veerle Vanvoorden

Veerle Vanvoorden publishes mostly in Immunology, Oncology and Rheumatology, on topics such as Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments and Autoimmune Bullous Skin Diseases.

ORCID 0000-0003-0300-2872 OpenAlex
World rank
#1,217,511
of 7,710,434 ranked researchers
Rank in Belgium
#11,137
of 67,186
Works
36
Citations
1.9k
Citations per work
53.5
h-index
14
i10-index 15Top 52% in Immunology

What does Veerle Vanvoorden research?

Veerle Vanvoorden's work is mostly in Medicine (39%), Immunology and Microbiology (29%), Economics, Econometrics and Finance (8%).

Life Sciences29%Health Sciences39%Social Sciences8%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1439.0%
    1. Immunology and Microbiology1028.6%
  1. Everything else924.8%
    1. Economics, Econometrics and Finance37.6%
  1. 1Immunology29% of their works
  2. 2Oncology14% of their works
  3. 3Rheumatology10% of their works
  4. 4Dermatology8% of their works
  5. 5Pathology and Forensic Medicine8% of their works
  6. 6Economics and Econometrics8% of their works

Research topics

Which keywords describe Veerle Vanvoorden's research?

The keywords of their largest research topics: IL-17, TH17 Cells, Quality of Life, Ankylosing Spondylitis, Spondyloarthritis, Autoantibodies, Pemphigoid and Filaggrin.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. IL-17261 topic
  2. TH17 Cells261 topic
  3. Quality of Life122 topics
  4. Ankylosing Spondylitis91 topic
  5. Spondyloarthritis91 topic
  6. Autoantibodies81 topic
  7. Pemphigoid81 topic
  8. Filaggrin71 topic
  9. Skin Microbiome71 topic
  10. Cancer Survivorship61 topic
  11. Cost-effectiveness Analysis61 topic
  12. Health Utility Measures61 topic
  13. Patient-Reported Outcomes61 topic
  14. Cetuximab41 topic
  15. Fc Receptors41 topic
  16. KRAS Mutations41 topic
  17. Therapeutic Antibodies41 topic

Where does Veerle Vanvoorden work?

Veerle Vanvoorden's main affiliation in the publication record is UCB Pharma (Belgium), Belgium.

How many publications and citations does Veerle Vanvoorden have?

OpenAlex counts 36 works and 1,925 citations for Veerle Vanvoorden, an h-index of 14, ranking #1,217,511 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Veerle Vanvoorden. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.